How Long Does Semaglutide Stay in Your System?

    By Trimi Medical Team4 min read

    Semaglutide has a half-life of approximately 7 days (168 hours), meaning it takes about one week for half of the drug to be eliminated from your body. Complete clearance requires approximately 5-7 weeks (5 half-lives) after your last injection. This long duration in the body is why semaglutide is dosed once weekly rather than daily.

    Medical Disclaimer: This article is for informational purposes only. Do not adjust your dosing schedule without consulting your healthcare provider.

    Understanding Semaglutide's Half-Life

    A drug's half-life is the time it takes for the concentration in your bloodstream to decrease by 50%. Here is how semaglutide levels decline after your last dose:

    • 1 week after last dose: ~50% of the drug remains
    • 2 weeks: ~25% remains
    • 3 weeks: ~12.5% remains
    • 4 weeks: ~6.25% remains
    • 5 weeks: ~3.1% remains (considered effectively eliminated)

    Why This Matters

    Side Effects After Stopping

    Because semaglutide clears slowly, side effects like nausea do not disappear immediately after your last injection. Most GI side effects resolve within 2-4 weeks as drug levels decline below the threshold for GI effects. However, appetite suppression may persist at low levels for the full 5-7 week clearance period.

    Transitioning Between Medications

    If switching from semaglutide to another GLP-1 (such as tirzepatide), providers consider the overlapping drug levels. Some overlap may increase side effects. Your provider will advise on appropriate timing for the transition.

    Surgery Considerations

    Because semaglutide slows gastric emptying, many anesthesiologists require patients to stop the medication before surgeries requiring general anesthesia to reduce aspiration risk. The American Society of Anesthesiologists recommends holding GLP-1 medications for at least one week before elective surgery, though recommendations vary by institution.

    Pregnancy Planning

    Semaglutide is not recommended during pregnancy. Women planning to conceive should discontinue semaglutide at least 2 months (8 weeks) before attempting pregnancy to ensure the drug is fully cleared.

    Steady State and Weekly Dosing

    Because of the 7-day half-life, semaglutide accumulates during weekly dosing and reaches "steady state" (consistent blood levels) after approximately 4-5 weeks at any given dose. This is why the medication's full effect is not felt immediately when starting or changing doses.

    Frequently Asked Questions

    How long does semaglutide stay in your system?

    Approximately 5-7 weeks after your last injection. Semaglutide has a half-life of about 7 days, requiring 5 half-lives for effective elimination.

    How long do side effects last after stopping semaglutide?

    Most side effects resolve within 2-4 weeks. Appetite suppression may persist longer, gradually fading over 5-7 weeks.

    Does semaglutide show up on drug tests?

    No. Semaglutide is not a controlled substance and is not tested for in standard drug screening panels.

    For expert guidance on semaglutide dosing and treatment planning, explore Trimi's treatment programs.

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Related Reading

    What does the published clinical evidence show for compounded semaglutide?

    Peer-reviewed evidence: Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021). Trimi offers compounded semaglutide starting at $99/month on the annual plan, dispensed by 503A community sterile compounding pharmacies (VialsRx — Texas pharmacy license #35264 — and GreenwichRx). Results vary by individual; eligibility is determined by a licensed clinician.

    Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. — STEP 1, NEJM 2021
    Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. — STEP 4, JAMA 2021
    Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. — SELECT, NEJM 2023

    Key Takeaways

    • Adults with overweight or obesity on semaglutide 2.4 mg achieved a mean body weight reduction of approximately 14.9% at 68 weeks, compared with 2.4% on placebo. (Source: STEP 1, NEJM 2021)
    • Approximately 86% of patients on continued semaglutide treatment maintained ≥5% body-weight reduction from baseline through 68 weeks, vs 33% in the placebo-switch arm. (Source: STEP 4, JAMA 2021)
    • Semaglutide 2.4 mg reduced major adverse cardiovascular events (MACE) by 20% over a mean 39.8-month follow-up in adults with overweight/obesity and pre-existing cardiovascular disease without diabetes. (Source: SELECT, NEJM 2023)
    • Semaglutide is the active pharmaceutical ingredient; it is FDA-approved in the corresponding brand finished products (Wegovy and Ozempic). Trimi's compounded preparation of the same active ingredient is prepared per individual prescription by 503A community sterile compounding pharmacies and is not itself FDA-approved as a drug.
    • Eligibility requires evaluation by a licensed clinician: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease). Contraindications include personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis, severe gastrointestinal disease, severe renal impairment, pregnancy, and breastfeeding.
    • Common GLP-1 receptor agonist adverse effects include nausea, vomiting, diarrhea, constipation, and gallbladder events. Dose titration over weeks improves tolerability. Severe gastrointestinal symptoms may cause dehydration and increase acute kidney injury risk.
    • This is general information based on the cited evidence, not medical advice. Treatment decisions require evaluation by a licensed clinician familiar with your individual medical history, BMI, and comorbidities.

    Medically Reviewed

    TMRT

    Trimi Medical Review Team

    Clinical review workflow for GLP-1 safety, dosing, and access content

    Team-based medical review process documented in Trimi's Medical Review Policy

    Last reviewed: February 26, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Trimi Medical Review Team, Clinical review workflow for GLP-1 safety, dosing, and access content

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    21 lbs down in 6 weeks! So happy I started with you guys!

    Outcome: 21 lbs lost in 6 weeks

    Robyn Lynn CurtisFacebook
    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2032183
    2. Rubino D, Abrahamsson N, Davies M, et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA.Read StudyDOI: 10.1001/jama.2021.3224
    3. Garvey WT, Batterham RL, Bhatta M, et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine.Read StudyDOI: 10.1038/s41591-022-02026-4
    4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2307563
    5. Marso SP, Bain SC, Consoli A, et al. (2016). Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa1607141
    6. Perkovic V, Tuttle KR, Rossing P, et al. (2024). Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes (FLOW). New England Journal of Medicine.Read StudyDOI: 10.1056/NEJMoa2403347

    Was this article helpful?

    Keep Reading

    Complete guide to semaglutide 1.7mg dosing. Learn about expected weight loss results, side effects at this higher dose, and how to decide between staying at 1.7mg or advancing to 2.4mg.

    FDA approved oral Wegovy (semaglutide 50mg tablet) for weight loss in 2026. Review covers clinical trial results (~15% body weight loss), dosing, side effects, cost ($1,000–$1,500/mo), and affordable injectable alternatives.

    Complete guide to using Ozempic for weight loss. Learn about off-label prescribing, Ozempic vs Wegovy dosing differences, insurance, and why compounded semaglutide may be a better option.

    Discover real semaglutide before and after results with a month-by-month timeline. See what weight loss to expect at 1, 3, 6, and 12 months based on clinical data.

    Start your GLP-1 journey — from $99/mo

    Get Started